400
Participants
Start Date
October 30, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment
"Drug: Ribostat riboflavin and sodium iodide ophthalmic solution~Device: UV-3000 ultraviolet A light source"
Placebo and sham treatment
"Drug: placebo ophthalmic solution~Device: UV-3000 light source"
The Eye Doctors at CNY Eye Care, East Syracuse
UPMC Vision Institute, Pittsburgh
Wills Eye Hospital, Philadelphia
University of Virginia, Charlottesville
Center for Excellence in Eye Care, Miami
Cincinnati Eye Institute, Cincinnati
Chicago Cornea Consultants, Hoffman Estates
Ophthalmology Associates, St Louis
Baylor College of Medicine, Houston
Nvision Eye Centers Rowland Heights, Rowland Heights
Goodman Eye Center, San Francisco
Devers Eye Institute, Portland
Boston Vision, Brookline
Lead Sponsor
Epion Therapeutics
INDUSTRY